Clinical trials sponsored by Shanghai Chest Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Shanghai Chest Hospital

• A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
  NCT06152107 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
  NCT07091305 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer
  NCT04977791 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRI
  NCT07045532 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer
  NCT06818149 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• China Lung Cancer Screening (CLUS) Study Version 3.0
  NCT05494021 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 75 Years · Sex: All (male and female) · 1 location
• Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery
  NCT07515027 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations
  NCT05271916 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
  NCT06483295 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
  NCT07632365 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC
  NCT06663306 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.
  NCT07681245 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 5 locations
• Molecular Analysis and Treatment Options of SCLC
  NCT05945745 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
  NCT06437977 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation
  NCT07122336 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan
  NCT06358222 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
  NCT07541521 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 10 locations
• Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)
  NCT07564557 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC
  NCT07135856 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Transbronchial MWA for Pulmonary Tumors
  NCT06969014 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
  NCT06503744 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Shanghai Chest Hospital recruiting for?

Shanghai Chest Hospital is the lead sponsor of 21 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.